Purchase Order FA864924P0274
- Not listed
- The U.S. Air Force Research Laboratory (AFRL) awarded a $74,948.00 Firm Fixed Price Purchase Order to Perfusion Medical LLC, a small business, for the research and development of PEG-20K/8K, a patented intravenous solution to treat hemorrhagic shock. This Small Business Technology Transfer (STTR) Phase I contract supports Perfusion Medical's efforts to commercialize its novel pipeline product, PEG-20K IV solution, which was originally developed by researchers at Virginia Commonwealth University....
- The Air Force Research Laboratory has awarded a $1.8 million Small Business Technology Transfer (STTR) Phase II purchase order to Perfusion Medical LLC for conducting human clinical trials to assess the safety of PM-208, an anti-shock drug. The contract, set aside for small businesses, carries a firm fixed price and extends through January 2027. Perfusion Medical is a small biotechnology company specializing in innovative intravenous solutions for acute medical conditions, with particular...
- The Defense Health Agency (DHA) awarded a $2.99 million Small Business Innovation Research (SBIR) Phase II direct contract to Perfusion Medical LLC on September 15, 2023, under Proposal H2D-0122. The contract, designated as a Total Small Business set aside, funds IND-enabling studies for PM-208, a novel pre-hospital anti-shock therapeutic. Work will be performed in Herndon, Virginia, with an ultimate completion date of July 14, 2026. This firm fixed-price definitive contract represents a...
- The Air Force Research Laboratory (AFRL) awarded a $1.25 million firm fixed-price purchase order to NKA Bio, Inc., a small business, for Phase II of a Small Business Innovation Research (SBIR) program focused on developing an anti-shock injection to improve combat casualty care. The contract, awarded on July 15, 2025, with an ultimate completion date of January 15, 2027, is designated as a Total Small Business set-aside. Performance will take place at NKA Bio's facility in Baltimore, Maryland....
- <p>This is a $74,836 firm fixed-price purchase order awarded by the Air Force Research Laboratory (AFRL) to Monumedical, LLC, a small business, under the SBIR (Small Business Innovation Research) Program Phase I. The contract is for the development of the MINIFUSER infusion device for prolonged field care. The period of performance for this award is from January 17, 2025, to April 17, 2025.</p>
- The U.S. Air Force Research Laboratory awarded a $749,886 Small Business Innovation Research (SBIR) Phase II contract to 410 Medical, Inc. to develop a "New Handheld Rapid Infuser Ultra for Warfighter Resuscitation at the Point of Injury." 410 Medical is a medical device manufacturer that specializes in products for urgent trauma care and rapid resuscitation, including the LifeFlow hand-operated infuser. The Air Force has awarded multiple SBIR, STTR, and purchase order contracts to 410...
- The U.S. Air Force Research Laboratory (AFRL) awarded a $1,245,650.00 SBIR Phase II contract to Nanoguard Medical Solutions, LLC, a small disadvantaged business, for the development of a "SAVING LIVES IN COMBAT - A REVOLUTIONARY NANOFIBER WOUND CARE" product. The contract is a firm fixed-price purchase order with a period of performance through February 17, 2026. This SBIR Phase II action is part of the AFRL's efforts to support the development of innovative technologies for defense...
- The U.S. Air Force Research Laboratory (AFRL) awarded a $72,672.00 Small Business Innovation Research (SBIR) Program Phase I firm-fixed-price purchase order to NKA Bio, Inc. for the development of an anti-shock toxin antibody drug for combat casualty care. The contract has a completion date of December 17, 2024. As a small disadvantaged business, NKA Bio, Inc. was awarded this SBIR Phase I contract to perform research and development related to the delivery of a medical countermeasure for combat...
- This is a $1,249,986.00 firm fixed-price purchase order awarded by the Air Force Research Laboratory (AFRL) to Monumedical, LLC, a small business located in Penryn, California. The contract is for the development of the EZFUSER(TM) DISPOSABLE INFUSER as part of the Small Business Innovation Research (SBIR) Program Phase II. The EZFUSER is a specialized medical infusion device designed for military and prolonged field care applications. This contract is designated as a total small business...
- This is a $1,499,987.16 Firm Fixed Price Definitive Contract awarded by the U.S. Army Medical Command (MEDCOM) to Cytosorbents Medical Inc., a small business manufacturer, under the Small Business Innovation Research (SBIR) program. The contract is for medical research and development to investigate a potassium adsorber for treating hyperkalemia resulting from traumatic injury and acute kidney injury in austere environments. This is a Phase II SBIR action with a completion date of February 20,...
The U.S. Air Force Research Laboratory awarded a $74,975 firm fixed price Small Business Innovation Research (SBIR) Phase I purchase order to Perfusion Medical LLC, a biotechnology company, for the research and development of PEG-20K/8K, a patented intravenous solution for the treatment of acute kidney injury, septic shock, and hemorrhagic shock. The contract is set aside for small businesses. Perfusion Medical LLC is commercializing this solution, which was developed by researchers at Virginia Commonwealth University, and is working in partnership with the Mayo Clinic on this effort. Additionally, the company has received other SBIR Phase II and STTR Phase I awards from the Air Force Research Laboratory and the Defense Health Agency to further advance the development of this anti-shock therapeutic.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $75.0k | 12/11/23 |